diabetes
Go for the Gold: How to determine your risk for diabetes
Sep. 11, 2020—One in nine American adults has diabetes, and one in three has pre-diabetes. Prevention and early intervention can decrease the risk of complications down the road.
Vanderbilt historian explores impact of racism, classism on understanding diabetes
Aug. 19, 2020—Research by Vanderbilt history professor Arleen Tuchman on the cultural history of diabetes offers important lessons for other public health challenges, including COVID-19.
Keeping beta cells “fit”
Jul. 9, 2020—Vanderbilt cell biologists are defining the factors that help beta cells in the pancreas stay healthy, secrete insulin and prevent diabetes initiation and progression.
Race, hormones and diabetes risk
Apr. 8, 2020—Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease.
Post-transplant diabetes may be reversible: study
Feb. 20, 2020—Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.
Wellcast: Learn about new diabetes treatment technology
Dec. 11, 2019—Shichun Bao, associate professor of medicine and the Diabetes Technology Program leader in the Division of Endocrinology at the Eskind Diabetes Clinic, shares information on the amazing technological advances in diabetes treatment and blood sugar management.
Genetic screen in worms reveals critical step in insulin synthesis
Dec. 4, 2019—The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.
Diabetes drug study explores cardiovascular risks for patients with kidney disease
Sep. 25, 2019—An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.
Healthy adults needed for research study
Aug. 22, 2019—The purpose of this study is to measure a metabolite called α-aminoadipic acid (2-AAA) in blood. Different amounts of 2-AAA in the body may alter the risk of developing diabetes
Discovery may point to better treatments for Type 1 diabetes
Aug. 22, 2019—Researchers have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with Type 1 diabetes.
New role for microtubules in diabetes
Jul. 29, 2019—Microtubules, part of the cell's cytoskeleton, regulate the secretion of insulin, suggesting that they may be a new target for treating diabetes.
Deadline for diabetes and obesity research grants is Sept. 9
Jul. 22, 2019—The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC), and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of Pilot and Feasibility Grants in diabetes or obesity-related research.